| N | % |
---|---|---|
Fibrosis (N = 17) |  |  |
Improved | 0 | 0 |
Unchanged | 16 | 94.1% |
Worsened | 1 | 5.9% |
Bile duct proliferation (N = 17) |  |  |
Improved | 0 | 0 |
Unchanged | 15 | 88.2% |
Worsened | 2 | 11.8% |
Cholestasis (N = 17) |  |  |
Improved | 3 | 17.6% |
Unchanged | 13 | 76.5% |
Worsened | 1 | 5.9% |
Portal and periportal inflammation (N = 17) |  |  |
Improved | 1 | 5.9% |
Unchanged | 16 | 94.1% |
Worsened | 0 | 0 |
Duct plate malformation (N = 17) |  |  |
Improved | 0 | 0 |
Unchanged | 17 | 100% |
Worsened | 0 | 0 |